Host: Benjamin Levy, MD

Guest: Rebecca Heist, MD, MPH

Guest: Peter Bela Illei, MD

Antibody-drug conjugates (ADCs) have promising clinical data in the treatment of advanced non-small cell lung cancer. Listen in as Drs. Benjamin Levy, Rebecca Heist, and Peter Illei discuss current data on TROP2 ADCs and what this means for our patients.